Resources

Effective Study Design and Execution of Renal and Hepatic Impairment Trials

Effective Study Design and Execution of Renal and Hepatic Impairment Trials

As most medications are primarily excreted through the kidneys or liver, most drugs in development will require a renal ...
How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator

How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator

In today’s rapidly evolving pharmaceutical landscape, cognitive safety is emerging as a critical factor that can set ...
From Chance Discovery to Molecular Biology

From Chance Discovery to Molecular Biology

Dr. Sheldon H. Preskorn's presentation, "From Chance Discovery to Molecular Biology," highlights the evolution of ...
Accelerating Clinical & Drug Development Timelines with AI

Accelerating Clinical & Drug Development Timelines with AI

As the drug development landscape rapidly evolves, artificial intelligence (AI) is emerging as a transformative force, ...
Updates on Human Abuse Potential Studies: Challenges and Regulatory Guidelines

Updates on Human Abuse Potential Studies: Challenges and Regulatory Guidelines

Discover this groundbreaking webinar delving into the latest insights from the CCALC and the FDA in drug development and clinical evaluation of human drug abuse and dependence potential.